mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels

Clinical trial NCT04923386 · COMPLETED

Trial details

NCT number: NCT04923386
Sponsor: Levenson, David I., M.D.
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Hyperglycemia Vaccine Adverse Reaction

Start date: 2021-06-15
Primary completion: 2021-12-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.